U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07899333) titled 'Impact of Delivery Mode on Infant Gut Microbiota, Visceral Sensitivity, and the Neuroenteri... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07897370) titled 'Cardiac Arrest - Ultrasound Detection of Occult Perfusion' on Oct. 09. Brief Summary: The ... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07899450) titled 'Comparison of Two Autologous Sling Procedures for Stress Urinary Incontinence in Women' on ... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07898891) titled 'Generative AI and Gamified Simulation-Based Train-the-Trainer Basic Life Support Training f... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896382) titled 'COMPARATIVE EFFECTS OF SENSORY REWEIGHTING AND PROPRIOCEPTIVE FACILITATION TRAINING ON BALA... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07897760) titled 'Evaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in Pe... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07897279) titled 'Evaluation of Assisted Reproductive Technology (ART) Outcomes in Couples With Nonobstructiv... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896486) titled 'A Single-Center, Open-Label Study to Assess the Efficacy and Tolerability of a Brightening ... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07897617) titled 'Diaphragm Ultrasound and Rapid Shallow Breathing Index for Predicting Extubation Success' o... Read More
U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896590) titled 'Orelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone Lymphoma'... Read More